查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球声带增强市场
市场调查报告书
商品编码
1272776

2023-2030 年全球声带增强市场

Global Vocal Fold Augmentation Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

全球声带增强市场预计将实现利润丰厚的增长，到 2022 年将达到 20.428 亿美元，到 2030 年将达到 26.428 亿美元。 声带增强市场预计在预测期内（2023-2030 年）的复合年增长率为 3.3%。 主要参与者正在采取併购、合作伙伴关係和区域扩张等战略，以在声带增强市场中脱颖而出，成为强有力的竞争者。 除了高度重视研发外，新产品发布是大公司提高市场占有率的另一种方式。

例如，2020 年 11 月 6 日，Thyssen'sche Handelsgesellschaft mbH (THG) 立即收购了 SPIGGLE &THEIS Medizintechnik GmbH（“SPIGGLE &THEIS”）的多数股权。 此外，2020 年 12 月 18 日，APrevent 和 hearLIFE 签署了 APrevent VOIS 在韩国、新加坡、马来西亚、泰国、印度尼西亚、越南、柬埔寨、老挝、缅甸和文莱的独家经销协议。

竞争因素，例如市场进入者扩大地理足迹，通过多种产品发布和新兴市场扩张加强客户群，预计将在预测期内推动市场增长。

声带增强术是一种增强声带功能的医疗程序。 它包括使用声带注射来治疗轻度至中度声门反流的各种永久性原因，例如声带萎缩，麻痹和瘫痪。 此外，它还可用于先前框架手术后的增强。

全球声带增强市场预计将在未来几年出现显着增长，原因有多种因素，例如与声音相关的问题案例不断增加、医疗保健意识不断增强以及技术进步。.

此外，老年人口的增加和对微创手术的需求不断增长也有望推动市场增长。 在过去十年中，声带注射作为治疗各种喉部疾病的一种有价值的治疗方法的出现也促进了市场的增长。

市场动态

预计喉癌患者数量的增加将推动全球声带增强市场的增长

全球声带增强市场是由日益普遍的嗓音问题（包括喉癌）推动的。 例如，根据美国癌症协会的数据，每年大约有 13,150 例新的喉癌病例，HPV 感染、吸烟和饮酒等风险因素导致病例增加。 因此，对声带增强以改善喉部疾病患者的发声功能的需求不断增长。

全球声带增强市场可能面临熟练专业人员短缺的製约

随着对优质医护人员需求的增加，声带增强市场也受到医护人员短缺的影响。 据 usnews.com 报导，预计到 2025 年，美国将面临一些卫生专业人员的短缺，包括家庭佣工、护理助理、医疗和实验室技术人员以及护士。 这些短缺在某些职业中最为明显和引人注目，并可能导致在满足声带成形术和治疗需求方面面临挑战。

COVID-19 影响分析

COVID-19 疫情对全球声带增强市场产生了重大影响，导致医疗器械和设备的供应炼和製造中断。 这导致了延误和短缺，影响了市场上产品和服务的可用性。 此外，许多医疗机构正在缩减或推迟择期手术，包括声带增强手术，以优先考虑 COVID-19 患者并降低感染风险。

然而，儘管存在这些挑战，如果由于嗓音障碍患病率的增加以及市场对创新手术技术和新产品的需求不断增长而导致大流行情况有所改善，则市场有望復苏。 许多製造商和服务提供商也通过提供远程医疗服务和为医疗保健专业人员开发虚拟培训和支持计划来适应这一流行病。

俄乌衝突分析

当前俄罗斯和乌克兰之间的衝突可能通过阻塞製造和分销渠道对声带增强市场产生间接影响，导致产品供应短缺和成本上升，对企业的影响可能是巨大的。

然而，儘管存在这些挑战，但由于医疗保健意识的提高以及与声音相关的疾病患病率的上升，从长远来看，该市场预计会扩大。 这有望为同行业的其他公司带来商机。 儘管战争的短期影响和持续的大流行可能会造成破坏，但从长远来看，市场有望復苏并继续繁荣。 因此，跟踪衝突对全球医疗保健行业的影响至关重要。

内容

第一章调查方法及范围

  • 调查方法
  • 调查目的和范围

第 2 章定义和概述

第 3 章执行摘要

  • 按材料类型分类的片段
  • 按治疗类型
  • 最终用户
  • 区域摘要

第四章市场动态

  • 影响因素
    • 主持人
      • 预计喉癌患者的增加将推动全球声带增强市场的增长
    • 约束因素
      • 缺乏熟练的专业人员可能会限制全球声带增强市场的增长
    • 机会
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 价格分析
  • 法律法规分析

第 6 章 COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情景
    • 当前的 COVID-19 情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格和动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按材料类型分类

  • 羧甲基纤维素
  • 羟基磷灰石钙
  • 透明质酸
  • 丝绸
  • 凝胶泡沫
  • 脂肪和油
  • 其他

第 8 章按治疗类型分类

  • 临时的
  • 常任

第 9 章最终用户

  • 医院
  • 专科门诊
  • 其他

第10章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第11章竞争格局

  • 竞争场景
  • 市场情况/份额分析
  • 併购分析

第12章公司简介

  • Merz Holding GmbH & Co KG（Merz Pharmaceuticals, LLC）
    • 公司概况
    • 产品组合和说明
    • 财务摘要
    • 主要发展状况
  • Sofregen Medical Inc.
  • Hoya Corporation（PENTAX Medical America, Inc.）
  • SPIGGLE & THEIS Medizintechnik GmbH
  • Inhealth Technologies
  • APrevent Medical Inc.
  • Boston Medical Products, Inc.
  • ReGen Scientific

第13章 附录

简介目录
Product Code: MD818

Market Overview

The global vocal fold augmentation market reached US$ 2,042.8 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 2,642.8 million by 2030. The vocal fold augmentation market is expected to exhibit a CAGR of 3.3% during the forecast period (2023-2030). The key players are adopting strategies such as mergers and acquisitions, partnerships, and regional expansion to stand out as strong competitors in the vocal fold augmentation market. New product launches along with increased focus on R&D are other ways the leading players improve their market presence.

For instance, on November 6, 2020, Thyssen'sche Handelsgesellschaft mbH (THG) acquired a majority stake in SPIGGLE & THEIS Medizintechnik GmbH ("SPIGGLE & THEIS") with immediate effect. Moreover, on December 18, 2020, APrevent and hearLIFE signed the exclusive distribution agreement for APrevent VOIS in Korea, Singapore, Malaysia, Thailand, Indonesia, Vietnam, Cambodia, Laos, Myanmar, and Brunei.

Fierce competition between market participants to expand their geographic footprints and strengthen their customer pool through several product launches & new product developments are major factors anticipated to drive market growth over the forecast period.

Vocal fold augmentation is a medical procedure that is performed to enhance the functioning of the vocal folds. It involves the use of vocal fold injection to treat various permanent causes of mild-to-moderate glottic insufficiency, such as vocal fold atrophy, paralysis, and paresis. Moreover, it can also be used for augmentation after previous framework surgery.

The global vocal fold augmentation market is expected to experience significant growth in the coming years, driven by various factors such as increasing cases of voice-related problems, rising awareness of healthcare, and advancements in technology.

Moreover, the growing geriatric population and rising demand for minimally invasive procedures are also expected to boost the market's growth. The emergence of vocal fold injection as a valuable treatment modality for a variety of laryngeal disorders in the past decade is also contributing to the market's growth.

Market Dynamics

The rising number of laryngeal cancer cases is expected to drive the growth of the global vocal fold augmentation market

The global vocal fold augmentation market is being driven by the increasing prevalence of voice problems, including laryngeal cancer. For instance, The American Cancer Society reports that there are around 13,150 new cases of laryngeal cancer each year, with risk factors such as HPV infection, tobacco use, and alcohol consumption contributing to the rise in cases. As a result, there is an increasing demand for vocal fold augmentation procedures to improve vocal function in patients with laryngeal disorders.

The global vocal fold augmentation market growth may face constraints due to a lack of skilled professionals

The vocal fold augmentation market is also affected by shortages in the healthcare workforce, as the demand for quality healthcare professionals increases. According to usnews.com, the U.S. is estimated to face shortages in several healthcare professions by 2025, including home health aides, nursing assistants, medical and lab technologists and technicians, and nurse practitioners. These shortages are most apparent and dramatic in certain professions, which could lead to challenges in meeting the demand for vocal fold augmentation procedures and treatments.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the global vocal fold augmentation market, causing disruptions in the supply chain and manufacturing of medical devices and equipment. This has resulted in delays and shortages, affecting the availability of products and services in the market. Moreover, many healthcare facilities have reduced or postponed elective procedures, including vocal fold augmentation surgeries, to prioritize COVID-19 patients and reduce the risk of transmission.

However, despite these challenges, the market is expected to recover as the pandemic situation improves, driven by the growing prevalence of voice disorders and the increasing demand for innovative surgical techniques and new products in the market. Many manufacturers and service providers have also adapted to the pandemic by offering telemedicine services and developing virtual training and support programs for healthcare professionals.

Russia-Ukraine Conflict Analysis

The current conflict between Russia and Ukraine could have an indirect effect on the vocal fold augmentation market by interrupting the manufacturing and distribution channels, resulting in shortages of supplies and higher costs for products that could have a greater impact on smaller firms.

However, despite these challenges, the market is projected to expand in the long run due to a growing awareness of healthcare and the rising prevalence of voice-related disorders. This is expected to create business opportunities for companies in the industry. Although the short-term effects of the war and the ongoing pandemic may cause disruptions, the market is predicted to rebound and continue to thrive over time. As a result, it is crucial to track the impact of the conflict on the global healthcare industry as a whole.

Segment Analysis

The global vocal fold augmentation market is segmented based on material type, treatment type, end user, and region.

The carboxymethylcellulose segment is expected to hold the highest vocal fold augmentation market share

The carboxymethylcellulose segment is expected to be the dominant segment in the global vocal fold augmentation market, holding 30.7% of the market share over the forecast period. The use of carboxymethylcellulose vocal cord injection is expected to be the leading technique in the global vocal fold augmentation market. Carboxymethylcellulose (CMC) is a thickening agent derived from cellulose obtained from materials such as wood pulp or cotton lint, which is reacted with a derivative of acetic acid (found in vinegar) and is also referred to as cellulose gum.

Gels made from carboxymethylcellulose (CMC) and cross-linked hyaluronic acid are commonly used as injectable materials for temporary or resorbable vocal fold medialization. For example, PROLARYN GEL, an aqueous/glycerin/carboxymethylcellulose gel implant, is used to augment the size of displaced or deformed vocal folds so that they can meet the opposing fold in the midline, leading to improved phonation. PROLARYN GEL is particularly suitable for short-term vocal fold augmentation or for patients who want to evaluate augmentation before undergoing long-term procedures.

Geographical Analysis

The presence of major players to dominate the North America region.

The vocal fold augmentation market is expected to grow significantly in North America region over the forecast period due to the presence of key market players who hold a major global vocal fold augmentation market share of around 2/5th and also due to an increase in cases of vocal fold paresis or paralysis (VFP) caused by COVID-19 vaccination, leading to dysphonia and respiratory distress.

To address these issues, several companies, such as Sofregen Medical, Inc., are developing products like Silk Voice, a soft tissue bulking agent injection that helps with vocal fold medialization and insufficiency. Silk Voice injection helps improve phonation by increasing the size of the displaced or malformed vocal fold, allowing it to converge with the opposing fold at the midline. An urgent indication for Silk Voice injection could be vocal fold insufficiency and severe aspiration issues.

Competitive Landscape

The major global players in the market include Merz Holding GmbH & Co KG(Merz Pharmaceuticals, LLC), Sofregen Medical Inc., Hoya Corporation(PENTAX Medical America, Inc.), SPIGGLE & THEIS Medizintechnik GmbH, Inhealth Technologies, APrevent Medical Inc., and Boston Medical Products, Inc., among others.

Why Purchase the Report?

  • To visualize the global vocal fold augmentation- market segmentation based on material type, treatment type, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global vocal fold augmentation market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global vocal fold augmentation market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Material Type
  • 3.2. Snippet by Treatment Type
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rising number of laryngeal cancer cases is expected to drive the growth of the global vocal fold augmentation market.
    • 4.1.2. Restraints
      • 4.1.2.1. The global vocal fold augmentation market growth may face constraints due to lack of skilled professionals.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Material Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.1.2. Market Attractiveness Index, By Material Type
  • 7.2. Carboxymethylcellulose
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Calcium Hydroxylapatite
  • 7.4. Hyaluronic Acid
  • 7.5. Silk
  • 7.6. Gelfoam
  • 7.7. Fats
  • 7.8. Others

8. By Treatment Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 8.1.2. Market Attractiveness Index, By Treatment Type
  • 8.2. Temporary
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Permanent

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Clinics
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Merz Holding GmbH & Co KG (Merz Pharmaceuticals, LLC) *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Sofregen Medical Inc.
  • 12.3. Hoya Corporation (PENTAX Medical America, Inc.)
  • 12.4. SPIGGLE & THEIS Medizintechnik GmbH
  • 12.5. Inhealth Technologies
  • 12.6. APrevent Medical Inc.
  • 12.7. Boston Medical Products, Inc.
  • 12.8. ReGen Scientific

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us